Covista Inc

Aktienanalyse zu Covista Inc (CVSA)

$134.470

-5.930 (-4.41%)Zum Schluss

Loading chart…
High
142.130
Open
140.680
VWAP
136.88
Vol
388.97K
Mkt Cap
Low
134.050
Amount
53.24M
EV/EBITDA, TTM
10.29

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.

AI analysis of Covista Inc (CVSA)

buy

Covista Inc is a good buy right now due to its strong earnings performance, with a reported EPS of $2.09, exceeding estimates by 10%, and a forward P/E ratio of 15.22, indicating potential for growth. Additionally, the stock has shown a solid year-to-date change of +36.46%, reflecting positive market sentiment. However, a key risk is the recent insider selling, where the CEO sold shares totaling approximately $690,000, which may raise concerns among investors about future performance.

Bewertungskennzahlen

The current forward P/E ratio for Covista Inc (CVSA) is 15.22, compared to its 5-year average forward P/E of 14.49.

Forward P/E

Fair
5Y Average P/E
14.49
Current P/E
15.22
Überbewertet
15.98
Unterbewertet
13.01

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.49
Current EV/EBITDA
10.29
Überbewertet
10.30
Unterbewertet
8.69

Forward P/S

Overvalued
5Y Average P/S
1.99
Current P/S
2.15
Überbewertet
2.12
Unterbewertet
1.86

Whales holding CVSA

A

Ariel Investments, LLC

+ HoldingCVSA

+3.35%

3M Return

Event-Zeitleiste

2026-08-06 (ET)

17:30:00

Sees FY27 Revenue at $2.05B-$2.09B

17:30:00

Covista Q4 Revenue of $501.4M Exceeds Expectations

2026-07-28 (ET)

08:30:00

Covista Appoints Emily Chiu and Leslie Storms to Board of Directors

2026-07-21 (ET)

09:30:00

Chamberlain University Opens New Campus in Salt Lake City

2026-05-07 (ET)

16:40:00

Raises FY Revenue Outlook to $1.93B-$1.945B

News

CVSA FAQ — answered by Alphio AI

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership. It operates in the Academic & Educational Services sector.

Covista Inc is a good buy right now due to its strong earnings performance, with a reported EPS of $2.09, exceeding estimates by 10%, and a forward P/E ratio of 15.22, indicating potential for growth. Additionally, the stock has shown a solid year-to-date change of +36.46%, reflecting positive market sentiment. However, a key risk is the recent insider selling, where the CEO sold shares totaling approximately $690,000, which may raise concerns among investors about future performance.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten